We will accelerate the development of cures through the power of collaboration so children with cancer can grow up to realize their full potential.
We put the health and wellbeing of children ahead of personal acclaim or institutional gain. The success of our work will be measured in healthy children.
We believe in the power of collaboration and trust that, together with our partners, we will go further, faster in developing cures. We will put aside individual egos to achieve our common goals.
We will challenge boundaries and be creative in pursuit of our mission. We are unconstrained by the status quo and prioritize the possibility of new discoveries that lead to new cures.
We have assembled a team of experts in the field of CAR T-cell science who are united behind our mission and values. We understand the importance of asking the big questions, the power of a common purpose, and the wonder of human potential.
Dr. Jensen is an internationally recognized leader in the field of CAR T-cell immunotherapy with over 20-years’ experience in the research and clinical translation of this therapeutic modality.
Dr. Lea brings over 25-years’ experience in research and development, operations, intellectual property management, and business development roles.
Dr. Orentas received his PhD from the Department of Pharmacology and Molecular Sciences of The Johns Hopkins University School of Medicine.
Our members are nationally recognized academic children’s hospitals who believe in the power of collaboration. Together, we will expand these innovative therapies to children in our communities, while redefining the state of care globally.